Clinical Trials Directory

Trials / Completed

CompletedNCT00701896

Smoking Cessation Using Motivational Therapy and Varenicline

Smoking Cessation and the Natural History of HIV-Associated Emphysema

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
294 (actual)
Sponsor
Philip Diaz · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

People that are infected with HIV appear to be especially susceptible to the adverse effects of cigarette smoking. The purpose of this study is to determine if quitting smoking by using a specialized smoking cessation treatment can prevent one from developing accelerated lung damage, particularly emphysema.

Detailed description

HIV-infected smokers are at increased risk for life-threatening diseases, such as pneumonia. To date, very little is known about the tobacco consumption characteristics of this at-risk population of smokers, but it has been well documented that they are at high risk for smoking-related co-morbidities. In addition, few effective cessation strategies have been described in HIV-infected populations. A specialized smoking cessation that combines recommendations from an existing scientifically-valid clinical guideline with Motivational Interviewing a new pharmacotherapeutic agent, may be an effective mechanism to apply to this vulnerable population of smokers. This initial, efficacy investigation has the potential to guide future treatment and research pertaining to tobacco cessation, respiratory illness and HIV.

Conditions

Interventions

TypeNameDescription
DRUGVarenicline tartrate1 mMg tablet form; daily during week 1 (pre-quit week) followed by 1 mg twice daily for weeks 2-12.
DRUGNicotine Replacement TherapyNicotine gum and nicotine patch
OTHERBiological ControlNo treatment intervention only information and procedures.
BEHAVIORALMotivational Interview60 minute one-on-one Interview

Timeline

Start date
2008-10-03
Primary completion
2013-04-20
Completion
2013-06-20
First posted
2008-06-19
Last updated
2021-01-15
Results posted
2021-01-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00701896. Inclusion in this directory is not an endorsement.